These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 2853991)

  • 1. [3H]U69,593 binding in guinea-pig brain: comparison with [3H]ethylketazocine binding at the kappa-opioid sites.
    Tiberi M; Payette P; Mongeau R; Magnan J
    Can J Physiol Pharmacol; 1988 Nov; 66(11):1368-72. PubMed ID: 2853991
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Quantitative analysis of multiple kappa-opioid receptors by selective and nonselective ligand binding in guinea pig spinal cord: resolution of high and low affinity states of the kappa 2 receptors by a computerized model-fitting technique.
    Tiberi M; Magnan J
    Mol Pharmacol; 1990 May; 37(5):694-703. PubMed ID: 2160061
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacological characterization of the binding of [3H]bremazocine in guinea-pig brain: evidence for multiplicity of the kappa-opioid receptors.
    Tiberi M; Magnan J
    Can J Physiol Pharmacol; 1989 Oct; 67(10):1336-44. PubMed ID: 2558788
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Demonstration of the heterogeneity of the kappa-opioid receptors in guinea-pig cerebellum using selective and nonselective drugs.
    Tiberi M; Magnan J
    Eur J Pharmacol; 1990 Jun; 188(6):379-89. PubMed ID: 2164939
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evidence for the presence of mu- and kappa- but not of delta-opioid sites in the human fetal brain.
    Magnan J; Tiberi M
    Brain Res Dev Brain Res; 1989 Feb; 45(2):275-81. PubMed ID: 2540923
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Interaction of endogenous opioid peptides and other drugs with four kappa opioid binding sites in guinea pig brain.
    Rothman RB; Bykov V; de Costa BR; Jacobson AE; Rice KC; Brady LS
    Peptides; 1990; 11(2):311-31. PubMed ID: 2162533
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Characterization of the kappa-subtype of the opiate receptor in the guinea-pig brain.
    Kosterlitz HW; Paterson SJ; Robson LE
    Br J Pharmacol; 1981 Aug; 73(4):939-49. PubMed ID: 6268235
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Opioid receptor ligands in the neonatal rat spinal cord: binding and in vitro depression of the nociceptive responses.
    James IF; Bettaney J; Perkins MN; Ketchum SB; Dray A
    Br J Pharmacol; 1990 Mar; 99(3):503-8. PubMed ID: 2158845
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Studies on the effects of glucose in vitro and of the glycaemic state in vivo on the binding characteristics of mu, delta and kappa opiate receptors in mouse brain.
    Khawaja XZ; Green IC
    Life Sci; 1992; 50(17):1273-81. PubMed ID: 1314928
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Selectivity of ligand binding to opioid receptors in brain membranes from the rat, monkey and guinea pig.
    Clark MJ; Carter BD; Medzihradsky F
    Eur J Pharmacol; 1988 Apr; 148(3):343-51. PubMed ID: 2898375
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Characterization of high affinity opioid binding sites in rat periaqueductal gray P2 membrane.
    Fedynyshyn JP; Kwiat G; Lee NM
    Eur J Pharmacol; 1989 Jan; 159(1):83-8. PubMed ID: 2540013
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Opioid ligand binding sites in the spinal cord of the guinea-pig.
    Zarr GD; Werling LL; Brown SR; Cox BM
    Neuropharmacology; 1986 May; 25(5):471-80. PubMed ID: 3016586
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Characterization of kappa opioid binding using dynorphin A1-13 and U69,593 in the rat brain.
    Devlin T; Shoemaker WJ
    J Pharmacol Exp Ther; 1990 May; 253(2):749-59. PubMed ID: 1971019
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mu antagonist properties of kappa agonists in a model of rat urinary bladder motility in vivo.
    Sheldon RJ; Nunan L; Porreca F
    J Pharmacol Exp Ther; 1987 Oct; 243(1):234-40. PubMed ID: 2822899
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Nalbuphine: an autoradiographic opioid receptor binding profile in the central nervous system of an agonist/antagonist analgesic.
    De Souza EB; Schmidt WK; Kuhar MJ
    J Pharmacol Exp Ther; 1988 Jan; 244(1):391-402. PubMed ID: 2826773
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Characterization of opioid receptors in intestinal muscle cells by selective radioligands and receptor protection.
    Kuemmerle JF; Makhlouf GM
    Am J Physiol; 1992 Aug; 263(2 Pt 1):G269-76. PubMed ID: 1325129
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Spectrum of the mu, delta- and kappa-binding sites in homogenates of rat brain.
    Gillan MG; Kosterlitz HW
    Br J Pharmacol; 1982 Nov; 77(3):461-9. PubMed ID: 6291693
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Opioid binding sites in the guinea pig and rat kidney: radioligand homogenate binding and autoradiography.
    Dissanayake VU; Hughes J; Hunter JC
    Mol Pharmacol; 1991 Jul; 40(1):93-100. PubMed ID: 1649966
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Localization of kappa opioid receptor binding sites in human forebrain using [3H]U69,593: comparison with [3H]bremazocine.
    Quirion R; Pilapil C; Magnan J
    Cell Mol Neurobiol; 1987 Sep; 7(3):303-7. PubMed ID: 2830975
    [TBL] [Abstract][Full Text] [Related]  

  • 20. High affinity [3H]ethylketazocine binding: evidence for specific kappa receptors.
    Wood PL; Charleson S
    Neuropharmacology; 1982 Mar; 21(3):215-9. PubMed ID: 6122185
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.